Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Be sure to tell your healthcare provider about all the medications you take, including prescription drugs, over-the-counter medicines, vitamins, and herbal supplements
IV therapy is gaining recognition as a supportive treatment for liver disease
A phase 1/2 study of lazertinib 240 mg in patients with advanced EGFR T790M-positive NSCLC after previous EGFR tyrosine kinase inhibitors
Another potent oral PARP1/2 inhibitor, niraparib (MK4827) binds to the active site of PARP enzymes, and studies indicate that Niraparib can restore NAD + levels and improve mitochondrial function 165,166
Amelioration of olfactory dysfunction in a mouse model of Parkinsons disease via enhancing GABAergic signaling
US$ 27.92
US$ 21.92
US$ 29.87
US$ 23.16
US$ 23.59
US$ 26.96
US$ 25.38
/product/19/3469114/1.jpg?9363)
